ANIXA BIOSCIENCES, INC. Increase (Decrease) in Accounts Receivable
ANIXA BIOSCIENCES, INC. (ANIX) reported Increase (Decrease) in Accounts Receivable of -$64.30 thousand for the 12-month period ending 2020-10-31, per its 10-K filed 2022-01-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2022-01-04
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2015-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2015-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2015-04-30 was -$45.00K, a 105.43% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2015-01-31 was -$355.00K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$64.30K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2015 was -$400.00K, a 277.78% decline from fiscal 2014.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2014 was $225.00K, a 28.57% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2013 was $175.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|
| 2020-10-31 | -$64.30K 10-K · filed 2022-01-04 | ||||
| 2017-07-31 | $221.05K 10-Q · filed 2017-09-08 | ||||
| 2015-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $0.00 derived: sum of 2 quarters · filed 2016-12-08 | -$45.00K derived: sum of 3 quarters · filed 2016-12-08 | -$400.00K 10-K · filed 2016-12-08 | |
| 2015-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | -$45.00K derived: sum of 2 quarters · filed 2016-08-19 | -$400.00K 10-Q · filed 2016-08-19 | -$133.33K derived: sum of 4 quarters · filed 2016-08-19 | |
| 2015-04-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | -$400.00K 10-Q · filed 2016-05-20 | -$133.33K derived: sum of 3 quarters · filed 2016-05-20 | -$828.37K derived: sum of 4 quarters · filed 2016-05-20 | |
| 2015-01-31 | -$355.00K 10-Q · filed 2015-03-09 | -$88.33K derived: sum of 2 quarters · filed 2015-12-23 | -$783.37K derived: sum of 3 quarters · filed 2015-12-23 | $45.00K derived: sum of 4 quarters · filed 2015-12-23 | |
| 2014-10-31 | $266.67K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$428.37K derived: sum of 2 quarters · filed 2015-12-23 | $400.00K derived: sum of 3 quarters · filed 2015-12-23 | $225.00K 10-K · filed 2015-12-23 | |
| 2014-07-31 | -$695.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $133.33K derived: sum of 2 quarters · filed 2015-08-18 | -$41.67K 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $828.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $653.37K 10-Q · filed 2015-05-22 | |||
| 2014-01-31 | -$175.00K 10-Q · filed 2015-03-09 | ||||
| 2013-10-31 | $175.00K 10-K · filed 2015-01-29 | -$175.00K 10-K/A · filed 2014-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |